436 related articles for article (PubMed ID: 26379790)
1. Magnetic Nanoparticles in Cancer Theranostics.
Gobbo OL; Sjaastad K; Radomski MW; Volkov Y; Prina-Mello A
Theranostics; 2015; 5(11):1249-63. PubMed ID: 26379790
[TBL] [Abstract][Full Text] [Related]
2. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
3. Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.
Xie W; Guo Z; Gao F; Gao Q; Wang D; Liaw BS; Cai Q; Sun X; Wang X; Zhao L
Theranostics; 2018; 8(12):3284-3307. PubMed ID: 29930730
[TBL] [Abstract][Full Text] [Related]
4. Upconversion-Magnetic Carbon Sphere for Near Infrared Light-Triggered Bioimaging and Photothermal Therapy.
Wang J; Yao C; Shen B; Zhu X; Li Y; Shi L; Zhang Y; Liu J; Wang Y; Sun L
Theranostics; 2019; 9(2):608-619. PubMed ID: 30809296
[TBL] [Abstract][Full Text] [Related]
5. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Bakhtiary Z; Saei AA; Hajipour MJ; Raoufi M; Vermesh O; Mahmoudi M
Nanomedicine; 2016 Feb; 12(2):287-307. PubMed ID: 26707817
[TBL] [Abstract][Full Text] [Related]
6. Emerging trends in aggregation induced emissive luminogens as bacterial theranostics.
Kumari R; Sunil D
J Drug Target; 2021 Sep; 29(8):793-807. PubMed ID: 33583291
[TBL] [Abstract][Full Text] [Related]
7. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
8. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ
Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998
[TBL] [Abstract][Full Text] [Related]
9. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine.
Moorthy H; Govindaraju T
ACS Appl Bio Mater; 2021 Feb; 4(2):1115-1139. PubMed ID: 35014470
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable nanoparticles as theranostics of ovarian cancer: an overview.
Chaurasiya S; Mishra V
J Pharm Pharmacol; 2018 Apr; 70(4):435-449. PubMed ID: 29380366
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
12. Magnetic mediators for ultrasound theranostics.
Józefczak A; Kaczmarek K; Bielas R
Theranostics; 2021; 11(20):10091-10113. PubMed ID: 34815806
[TBL] [Abstract][Full Text] [Related]
13. Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics.
Gan S; Lin Y; Feng Y; Shui L; Li H; Zhou G
Int J Nanomedicine; 2018; 13():4263-4281. PubMed ID: 30087559
[TBL] [Abstract][Full Text] [Related]
14. Magnetic nanoparticles for cancer theranostics: Advances and prospects.
Li X; Li W; Wang M; Liao Z
J Control Release; 2021 Jul; 335():437-448. PubMed ID: 34081996
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
16. Application and Importance of Theranostics in the Diagnosis and Treatment of Cancer.
Jeyamogan S; Khan NA; Siddiqui R
Arch Med Res; 2021 Feb; 52(2):131-142. PubMed ID: 33423803
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
18. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
19. Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma.
Zhu L; Mao H; Yang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1793. PubMed ID: 35396932
[TBL] [Abstract][Full Text] [Related]
20. Theranostic Nanoparticles for Pancreatic Cancer Treatment.
Jaidev LR; Chede LS; Kandikattu HK
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):203-214. PubMed ID: 32416712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
